CSIMarket
 


Cassava Sciences Inc  (PTIE)
Other Ticker:  
 

Cassava Sciences Inc's Tangible Leverage Ratio

PTIE's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




PTIE Tangible Leverage Ratio (Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Tangible Equity Change -12.66 % 108.55 % 80.13 % 102.37 % 75.72 %
Y / Y Total Liabilities Change 7.89 % -23.7 % 27.97 % -54.86 % -14.65 %
Tangible Leverage Ratio MRQ 0.05 0.06 0.05 0.03 0.04
Overall Ranking # # # # #
Seq. Tangible Equity Change -2.12 % -3.93 % -5.48 % -1.73 % 133.72 %
Seq. Total Liabilities Change -5.3 % 1.24 % 89.82 % -40.72 % -33.02 %



Tangible Leverage Ratio third quarter 2019 Comment
Due to repayements of liabilities of -5.3% Cassava Sciences Inc improved Tangible Leverage Ratio in third quarter 2019 to 0.05, below company's average Tangible Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the third quarter 2019, 11 other companies have achieved lower Tangible Leverage Ratio than Cassava Sciences Inc. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is PTIE Market Share?
Tangible Leverage Ratio third quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 12
Healthcare Sector # 22
Overall Market # 73


Tangible Leverage Ratio Statistics
High Average Low
3.33 0.57 0.02
(Dec 31 2012)   (Dec 31 2014)




Financial Statements
Cassava Sciences Inc's Tangible Equity $ 17 Millions Visit PTIE's Balance sheet
Cassava Sciences Inc's Total Liabilities $ 1 Millions Visit PTIE's Balance sheet
Source of PTIE's Sales Visit PTIE's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingSep 30 2019, within Major Pharmaceutical Preparations Industry Tangible Leverage RatioSep 30 2019 MRQ Total LiabilitiesSep 30 2019 MRQ Tangible Equity
Guardion Health Sciences, Inc.  0.15 $ 0.906  Millions$ 6.190  Millions
Kalvista Pharmaceuticals, Inc.  0.15 $ 14.277  Millions$ 97.787  Millions
Chimerix Inc  0.14 $ 15.803  Millions$ 111.948  Millions
Epizyme, Inc.  0.14 $ 40.459  Millions$ 293.738  Millions
Oragenics Inc  0.13 $ 2.698  Millions$ 20.819  Millions
Stemline Therapeutics Inc  0.13 $ 22.733  Millions$ 175.435  Millions
Xencor Inc  0.13 $ 76.007  Millions$ 596.210  Millions
Allogene Therapeutics, Inc.  0.12 $ 75.828  Millions$ 619.415  Millions
Catabasis Pharmaceuticals Inc  0.12 $ 4.632  Millions$ 38.273  Millions
Diamedica Therapeutics Inc.  0.12 $ 1.149  Millions$ 9.700  Millions
Essa Pharma Inc.  0.11 $ 5.593  Millions$ 49.181  Millions
Acadia Pharmaceuticals Inc  0.11 $ 76.297  Millions$ 686.335  Millions
Restorbio, Inc.  0.11 $ 12.199  Millions$ 109.764  Millions
Menlo Therapeutics Inc.  0.11 $ 9.574  Millions$ 87.002  Millions
Ngm Biopharmaceuticals Inc  0.11 $ 36.805  Millions$ 339.186  Millions
Zynerba Pharmaceuticals, Inc.  0.11 $ 9.145  Millions$ 85.013  Millions
Principia Biopharma Inc.  0.11 $ 16.365  Millions$ 152.675  Millions
Global Blood Therapeutics, Inc.  0.11 $ 69.251  Millions$ 658.097  Millions
Chiasma, Inc  0.10 $ 10.143  Millions$ 96.740  Millions
Iveric Bio, Inc.  0.10 $ 9.361  Millions$ 89.462  Millions
Crinetics Pharmaceuticals, Inc.  0.10 $ 12.986  Millions$ 129.523  Millions
Corcept Therapeutics Inc  0.10 $ 32.646  Millions$ 334.376  Millions
Magenta Therapeutics, Inc.  0.10 $ 15.704  Millions$ 161.529  Millions
Eton Pharmaceuticals, Inc.  0.09 $ 1.159  Millions$ 12.348  Millions
Adial Pharmaceuticals, Inc.  0.09 $ 0.777  Millions$ 8.724  Millions
Kura Oncology, Inc.  0.09 $ 20.771  Millions$ 233.584  Millions
Achillion Pharmaceuticals Inc  0.09 $ 19.126  Millions$ 217.216  Millions
Trevi Therapeutics, Inc.  0.09 $ 5.218  Millions$ 60.709  Millions
Mirati Therapeutics, Inc.  0.08 $ 36.209  Millions$ 434.489  Millions
Mirum Pharmaceuticals, Inc.  0.08 $ 12.070  Millions$ 146.203  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IX's Profile

Stock Price

IX's Financials

Business Description

Fundamentals

Charts & Quotes

IX's News

Suppliers

IX's Competitors

Customers & Markets

Economic Indicators

IX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071